MONFORTE, Pietro
 Distribuzione geografica
Continente #
EU - Europa 2.279
NA - Nord America 2.141
AS - Asia 1.155
SA - Sud America 340
Continente sconosciuto - Info sul continente non disponibili 38
AF - Africa 27
OC - Oceania 1
Totale 5.981
Nazione #
US - Stati Uniti d'America 2.088
RU - Federazione Russa 1.291
SG - Singapore 463
CN - Cina 331
BR - Brasile 282
IE - Irlanda 237
SE - Svezia 170
UA - Ucraina 140
VN - Vietnam 126
HK - Hong Kong 114
DE - Germania 110
GB - Regno Unito 88
IT - Italia 66
FR - Francia 59
FI - Finlandia 53
IN - India 27
AR - Argentina 24
CA - Canada 23
CZ - Repubblica Ceca 21
MX - Messico 16
EC - Ecuador 13
IQ - Iraq 13
PL - Polonia 12
BD - Bangladesh 11
TR - Turchia 10
CO - Colombia 9
UZ - Uzbekistan 7
BE - Belgio 6
ES - Italia 6
IR - Iran 6
MA - Marocco 6
SA - Arabia Saudita 6
TN - Tunisia 6
KG - Kirghizistan 5
PK - Pakistan 5
ZA - Sudafrica 5
ID - Indonesia 4
JP - Giappone 4
NL - Olanda 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CI - Costa d'Avorio 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
KE - Kenya 1
KR - Corea 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.947
Città #
Moscow 352
Ashburn 285
Singapore 271
Jacksonville 263
Dublin 237
Dallas 186
Chandler 182
San Jose 160
Nyköping 134
Hong Kong 114
Beijing 113
Dong Ket 70
Council Bluffs 62
Los Angeles 53
Dearborn 42
Cambridge 41
Medford 40
Princeton 40
The Dalles 36
Lauterbourg 35
Ann Arbor 33
Buffalo 30
Des Moines 30
Boardman 26
Lancaster 24
São Paulo 22
Brno 20
Munich 18
Columbus 17
Ho Chi Minh City 17
New York 17
Nanjing 16
Tianjin 15
Milan 14
Wilmington 13
Hanoi 12
San Mateo 12
Santa Clara 12
Houston 11
Shenyang 11
Guangzhou 10
Montreal 10
Warsaw 10
Jinan 9
Phoenix 9
Redondo Beach 9
San Francisco 9
Atlanta 8
Brooklyn 8
Frankfurt am Main 8
Shanghai 8
Turku 8
Edinburgh 7
Orem 7
Poplar 7
Rome 7
Stockholm 7
Tashkent 7
Zhengzhou 7
Ardabil 6
Belo Horizonte 6
Chennai 6
Chicago 6
Fuzhou 6
Hebei 6
Manchester 6
Mumbai 6
Ningbo 6
Quito 6
Baghdad 5
Bishkek 5
Brussels 5
Guayaquil 5
Haikou 5
Istanbul 5
Lahore 5
Medellín 5
Mercer Island 5
Nanchang 5
Rio de Janeiro 5
Augusta 4
Campinas 4
Changsha 4
Denver 4
Helsinki 4
Johannesburg 4
Ourinhos 4
Pune 4
Querétaro 4
Taizhou 4
Tunis 4
Amsterdam 3
Baku 3
Bologna 3
Casablanca 3
Conselheiro Lafaiete 3
Curitiba 3
Dakar 3
Florianópolis 3
Haiphong 3
Totale 3.427
Nome #
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 304
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 259
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 213
Anti-HIV agents: design and discovery of new potent RT inhibitors 185
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 172
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 171
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 166
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 161
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 161
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 160
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 152
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 150
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 146
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 143
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 143
Efficient 3D Database screening for novel HIV-1 IN inhibitors 142
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 139
Synthesis and structural features of new cyclofunctionalized benzimidazoles 137
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 136
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 131
Synthesis of new potential HIV-1 integrase inhibitors 131
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 129
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 127
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 124
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 123
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 121
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 118
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 118
ANTI-HIV AGENTS .1. SYNTHESIS AND INVITRO ANTI-HIV EVALUATION OF NOVEL 1H,3H-THIAZOLO[3,4-A]BENZIMIDAZOLES 115
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 114
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 110
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 108
Structural features and anti-human immunodeficiency virus (HIV) activity of the isomers of 1-(2',6'-difluorophenyl)-1H,3H- thiazolo[3,4-a]benzimidazole, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor 103
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 102
Analysis of the covenant of mayors initiative in sicily 101
SYNTHESIS AND ANTIHYPERTENSIVE ACTIVITY EVALUATION OF INDOLE- DERIVATIVES N-ACETAMIDO SUBSTITUTED 101
Air quality data for Catania: Analysis and investigation casestudy 2012-2013 99
Air quality data for Catania: Analysis and investigation case study 2010-2011 98
Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4- a]benzimidazoles 91
Synthesis and characterization of isomeric 2,3,3A,4-tetrahydro-1H-pyrrolo[1,2-A]benzimidazol-1-ones from 1,2-phenylenediamines and 3-acylpropionic acids 88
SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL DELTA(2)- 1,2,4-OXADIAZOLINE DERIVATIVES 85
Analysis of vertical profile of particulates dispersion in function of the aerodynamic diameter at a congested road in Catania 84
Synthesis and in vitro antitumor activity evaluation of 9- substituted 1,2,3,4-tetrahydrocarbazoles 74
NO2 concentration analysis in Urban area of Catania 73
STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANTITUMOR THIAZOLO[3,4- A]BENZIMIDAZOLE DERIVATIVES 73
Totale 5.981
Categoria #
all - tutte 19.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022157 0 0 0 7 14 0 10 11 2 2 30 81
2022/2023734 53 51 48 51 58 88 9 53 291 2 25 5
2023/2024147 11 22 6 43 13 27 1 0 0 5 2 17
2024/2025810 19 22 16 74 33 48 6 130 198 58 71 135
2025/20262.690 107 142 201 145 237 625 327 366 382 102 35 21
2026/2027397 36 87 134 140 0 0 0 0 0 0 0 0
Totale 5.981